1-3 of 3
Wing C. Chan
Close
Sort by
Journal Articles

Pharmacological profiling of a berbamine derivative for lymphoma treatment

Senlin Xu, Shunquan Wu, Mingfeng Zhang, Jun Xie, Min Lin, Lihua Jin, Jiawei Zhang, Yangmeng Wang, Mingjie Fan, Zhipeng Fang, Weini Li, Ching Ouyang, David Kwon, Natalie Que, Zhirou Li, Jinge Mao, Haonan Chen, Josephine Harris, Xiwei Wu, Jun Wu, Hongwei Yin, Wing C. Chan, David Horne, Wendong Huang
Journal: Blood Advances
Blood Adv (2024) 8 (2): 309–323.
https://doi.org/10.1182/bloodadvances.2023010873
Published: 2024
Includes: Supplemental data
Journal Articles

Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study

Clinical Trials & Observations
Aniket Bankar, Wing C. Chan, Ning Liu, Matthew Cheung, Shabbir Alibhai, Vikas Gupta
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5014–5026.
https://doi.org/10.1182/bloodadvances.2023009825
Published: 2023
Includes: Supplemental data
Journal Articles

Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines

Jibin Zhang, Tingting Wang, Kunal Shetty, Serhan Alkan, Senlin Xu, Qiang Gong, Xuxiang Liu, Yuping Li, Zunsong Hu, Wendong Huang, Hans-Guido Wendel, Alex F. Herrera, Raju K. Pillai, Joo Y. Song, Wing C. Chan
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5067–5071.
https://doi.org/10.1182/bloodadvances.2021006709
Published: 2022
Includes: Supplemental data